T 0593/24 (Combinations of a BTK inhibitor and a BCL-2 inhibitor/ACERTA) of 26.03.2026
- European Case Law Identifier
- ECLI:EP:BA:2026:T059324.20260326
- Date of decision
- 26 March 2026
- Case number
- T 0593/24
- Online on
- 26 May 2026
- Petition for review of
- -
- Application number
- 15757002.9
- IPC class
- A61K 45/06A61K 31/519A61K 31/437A61K 31/00A61K 31/454A61K 31/4985A61K 31/416A61K 31/675A61K 31/4468A61K 39/395A61K 31/4155
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR AND A BCL-2 INHIBITOR
- Applicant name
- Acerta Pharma B.V.
- Opponent name
- STADA Arzneimittel AG
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- Rules of procedure of the Boards of Appeal 2020 Art 013(1)European Patent Convention Art 83European Patent Convention Art 56
- Keywords
- Admittance of late-filed evidences - (yes)
Sufficiency of disclosure - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- G 0002/21
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.